Literature DB >> 10452761

Eosinophil influx to the nasal airway after local, low-level LPS challenge in humans.

D B Peden1, K Tucker, P Murphy, L Newlin-Clapp, B Boehlecke, M Hazucha, P Bromberg, W Reed.   

Abstract

BACKGROUND: Recent observations show that atopic asthmatic subjects have increased sensitivity to respirable endotoxin (or LPS) compared with normal persons. In vitro studies demonstrate that LPS enhances eosinophil survival. These observations suggest that the effects of inhaled LPS in asthmatic subjects may include increases in the number of airway eosinophils.
OBJECTIVE: We sought to determine whether low-level nasal LPS challenge causes an increase in eosinophil numbers in the nasal airways of atopic or normal subjects.
METHODS: Sixteen volunteers (10 atopic asthmatic subjects and 6 normal subjects) underwent 2 nasal challenge sessions. In one session, one nostril was challenged with saline and the other with 0. 1 microg of LPS. During the second session, 0.3 microg and 1.0 microg of LPS was delivered to each nostril, respectively. Nasal lavage fluid was obtained from each nostril before challenge, as well as 4 and 24 hours after challenge, and examined for the percent of total cells that were eosinophils and neutrophils, as well as cytokine levels.
RESULTS: LPS (1.0 microg) increased the percent of eosinophils in nasal lavage fluid 4 hours after challenge in atopic subjects only. There was also a correlation between constitutive nasal GM-CSF and eosinophil response to LPS in atopic subjects.
CONCLUSION: LPS challenge increases eosinophils in the airways of atopic subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452761     DOI: 10.1016/s0091-6749(99)70383-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

Review 1.  The presence of 3-hydroxy oxylipins in pathogenic microbes.

Authors:  Olihile M Sebolai; Carolina H Pohl; Lodewyk J F Kock; Vishnu Chaturvedi; Maurizio del Poeta
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-11-11       Impact factor: 3.072

2.  Nasal PMN response to repeated challenge with endotoxin in healthy volunteers.

Authors:  Vinod Doreswamy; Neil E Alexis; Haibo Zhou; David B Peden
Journal:  Inhal Toxicol       Date:  2011-02       Impact factor: 2.724

3.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 4.  Effect of pollutants in rhinitis.

Authors:  D B Peden
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

Review 5.  Association of CD14 -260 (-159) C>T and asthma: a systematic review and meta-analysis.

Authors:  Linlu Zhao; Michael B Bracken
Journal:  BMC Med Genet       Date:  2011-07-11       Impact factor: 2.103

6.  Cellular and molecular mechanisms in environmental and occupational inhalation toxicology.

Authors:  Herbert Riechelmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

Review 7.  Development of atopy and asthma: candidate environmental influences and important periods of exposure.

Authors:  D B Peden
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

8.  Effects of ozone and endotoxin coexposure on rat airway epithelium: potentiation of toxicant-induced alterations.

Authors:  J G Wagner; J A Hotchkiss; J R Harkema
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

9.  Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.

Authors:  Izabela Nita; Camilla Hollander; Ulla Westin; Sabina-Marija Janciauskiene
Journal:  Respir Res       Date:  2005-01-31

10.  Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness.

Authors:  Jaideep Dhariwal; Jeremy Kitson; Reema E Jones; Grant Nicholson; Tanushree Tunstall; Ross P Walton; Grace Francombe; Jane Gilbert; Andrew J Tan; Robert Murdoch; Onn Min Kon; Peter J Openshaw; Trevor T Hansel
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.